State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
By LabMedica International staff writers Posted on 28 Jul 2015 |
Top-of-the-line automated diagnostic systems are highlighted in Booth 2409 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).
Beckman Coulter Diagnostics (Brea, CA, USA) is displaying its state-of-the-art laboratory instruments at this year's meeting. Particular emphasis is being placed on the Power Express automation system for general clinical chemistry and the MicroScan WalkAway system for the microbiology lab.
Power Express is a connected clinical automation solution that consolidates all core disciplines—chemistry, immunochemistry, hematology, and coagulation—into a single automated line. Power Express performs multiple functions including sample login, centrifugation, decapping, aliquotting, presentation of samples for connected instruments, recapping, storing in ambient or refrigerated storage modules, and sorting to outlets. Intelligent sample management reduces variability and increases predictability because dynamic sample routing is based on test ordered and analyzers availability. Samples can crisscross and loop-back on track to analyzers, and smart carrier management ensures that high-throughput analyzers are optimized. Barcode sample reading at each sample aspiration maintains accuracy with positive patient identification.
The WalkAway plus microbiology system is the fourth generation of proven WalkAway technology and reliability. This platform delivers gold-standard accuracy for microorganism identification and susceptibility testing. It enables simultaneous processing of conventional, rapid, and specialty panels on a single, automated platform and delivers accurate resistance detection for emerging pathogens, including VISA, VRSA, and MRSA. The WalkAway plus System includes LabPro Information Management software designed to simplify workflow and minimize technologist interaction while accommodating differing regional and institutional environments through extensive customization features.
Visitors to the Beckman Coulter Diagnostics booth will be shown how the company is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity while minimizing errors and reducing turnaround time to improve physician confidence.
“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”
Related Links:
2015 AACC Annual Meeting & Clinical Lab Expo
Beckman Coulter Diagnostics
Beckman Coulter Diagnostics (Brea, CA, USA) is displaying its state-of-the-art laboratory instruments at this year's meeting. Particular emphasis is being placed on the Power Express automation system for general clinical chemistry and the MicroScan WalkAway system for the microbiology lab.
Power Express is a connected clinical automation solution that consolidates all core disciplines—chemistry, immunochemistry, hematology, and coagulation—into a single automated line. Power Express performs multiple functions including sample login, centrifugation, decapping, aliquotting, presentation of samples for connected instruments, recapping, storing in ambient or refrigerated storage modules, and sorting to outlets. Intelligent sample management reduces variability and increases predictability because dynamic sample routing is based on test ordered and analyzers availability. Samples can crisscross and loop-back on track to analyzers, and smart carrier management ensures that high-throughput analyzers are optimized. Barcode sample reading at each sample aspiration maintains accuracy with positive patient identification.
The WalkAway plus microbiology system is the fourth generation of proven WalkAway technology and reliability. This platform delivers gold-standard accuracy for microorganism identification and susceptibility testing. It enables simultaneous processing of conventional, rapid, and specialty panels on a single, automated platform and delivers accurate resistance detection for emerging pathogens, including VISA, VRSA, and MRSA. The WalkAway plus System includes LabPro Information Management software designed to simplify workflow and minimize technologist interaction while accommodating differing regional and institutional environments through extensive customization features.
Visitors to the Beckman Coulter Diagnostics booth will be shown how the company is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity while minimizing errors and reducing turnaround time to improve physician confidence.
“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”
Related Links:
2015 AACC Annual Meeting & Clinical Lab Expo
Beckman Coulter Diagnostics
Read the full article by registering today, it's FREE!

Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!

Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more